[go: up one dir, main page]

TR201900230A2 - PH ADJUSTED NOSE SOLUTION AND METHOD OF OBTAINING - Google Patents

PH ADJUSTED NOSE SOLUTION AND METHOD OF OBTAINING

Info

Publication number
TR201900230A2
TR201900230A2 TR2019/00230A TR201900230A TR201900230A2 TR 201900230 A2 TR201900230 A2 TR 201900230A2 TR 2019/00230 A TR2019/00230 A TR 2019/00230A TR 201900230 A TR201900230 A TR 201900230A TR 201900230 A2 TR201900230 A2 TR 201900230A2
Authority
TR
Turkey
Prior art keywords
obtaining
nose solution
adjusted
nasal
solution
Prior art date
Application number
TR2019/00230A
Other languages
Turkish (tr)
Inventor
Murat Mertoğlu Haci
Original Assignee
Haci Murat Mertoglu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haci Murat Mertoglu filed Critical Haci Murat Mertoglu
Priority to TR2019/00230A priority Critical patent/TR201900230A2/en
Priority to EP19890947.5A priority patent/EP3886812A4/en
Priority to US17/297,238 priority patent/US12128067B2/en
Priority to PCT/TR2019/050993 priority patent/WO2020112063A1/en
Publication of TR201900230A2 publication Critical patent/TR201900230A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu buluş, burun tıkanıklıklarının giderilmesi, burun içi temizliği ve tedavileri 5 için kullanılan nazal solüsyonun ile ilgili olup, bahsedilen nazal solüsyonun özelliği; belirli pH ajanlarının ve/veya pH tamponlarının miktarlarının ve kullanım kombinasyonlarının ayarlanması ile 7 - 11 pH aralığına sahip olmasıdır.This invention relates to the nasal solution used for the removal of nasal congestion, cleaning and treatment of nasal congestion 5, and the said nasal solution features; It has a pH range of 7 - 11 by adjusting the amounts and combinations of use of certain pH agents and/or pH buffers.

TR2019/00230A 2018-11-29 2019-01-08 PH ADJUSTED NOSE SOLUTION AND METHOD OF OBTAINING TR201900230A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2019/00230A TR201900230A2 (en) 2019-01-08 2019-01-08 PH ADJUSTED NOSE SOLUTION AND METHOD OF OBTAINING
EP19890947.5A EP3886812A4 (en) 2018-11-29 2019-11-25 NASAL SOLUTION WITH CLOSED BASIN NATURAL SPRING WATER CHARACTERISTIC AND METHOD FOR OBTAINING SAME NASAL SOLUTION
US17/297,238 US12128067B2 (en) 2018-11-29 2019-11-25 Nasal solution with closed basin natural spring water characteristic and method for obtaining said nasal solution
PCT/TR2019/050993 WO2020112063A1 (en) 2018-11-29 2019-11-25 A nasal solution with closed basin natural spring water characteristic and method for obtaining said nasal solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/00230A TR201900230A2 (en) 2019-01-08 2019-01-08 PH ADJUSTED NOSE SOLUTION AND METHOD OF OBTAINING

Publications (1)

Publication Number Publication Date
TR201900230A2 true TR201900230A2 (en) 2020-06-22

Family

ID=76328022

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/00230A TR201900230A2 (en) 2018-11-29 2019-01-08 PH ADJUSTED NOSE SOLUTION AND METHOD OF OBTAINING

Country Status (1)

Country Link
TR (1) TR201900230A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230338400A1 (en) * 2022-04-26 2023-10-26 Campbell Holding Company LLC Nasal rinse compositions and methods

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230338400A1 (en) * 2022-04-26 2023-10-26 Campbell Holding Company LLC Nasal rinse compositions and methods
US12350279B2 (en) * 2022-04-26 2025-07-08 Campbell Holdings Company Llc Nasal rinse compositions and methods

Similar Documents

Publication Publication Date Title
ZA202207804B (en) Compounds and uses thereof
WO2019014247A8 (en) Compositions comprising an rna polymerase inhibitor and cyclodextrin for treating viral infections
MX2022009308A (en) Compounds and uses thereof.
MX2023005436A (en) Compounds and uses thereof.
MA45616A (en) TARGET OLIGONUCLEOTIDE ANALOGUES LMNA HUMAN
MX390083B (en) (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE FORMULATIONS.
EA202091576A1 (en) CONNECTIONS
MY195437A (en) Methods of Treatment for Cholestatic and Fibrotic Diseases
MA48772B1 (en) Kras g12c inhibitors and methods of use thereof
MX380589B (en) METHODS OF TREATMENT AND PREVENTION OF ENDOTHELIAL DYSFUNCTION USING METHYL BARDOXOLONE OR ITS ANALOGUES.
MX2022009367A (en) Compounds and uses thereof.
MA46109A (en) HIGH CONCENTRATE, LOW VISCOSITY MASP-2 INHIBITOR ANTIBODY FORMULATIONS, KITS AND METHODS
MA45819A (en) COMPOSITIONS AND METHODS FOR TREATING DUCHENNE MUSCLE DYSTROPHY AND RELATED DISORDERS
MX2022009366A (en) Compounds and uses thereof.
WO2021022163A3 (en) Compounds and uses thereof
JOP20220119A1 (en) TREM2 antibodies and their uses
BR112017026061A2 (en) compound, use of a compound, and method of treating a viral infection
MX2017009038A (en) Lingo-1 antagonists and uses for treatment of demyelinating disorders.
BR112018012177A2 (en) 3 kv channel hydration modulators?
EA201890256A1 (en) 2-AMINO-3-Fluoro-3- (Fluoromethyl) -6-Methyl-6-phenyl-3,4,5,6-TETRAHYDROPYRIDINE AS BACE1 INHIBITORS
BR112019013468A8 (en) WIDELY NEUTRALIZING ANTI-HIV-1 ANTIBODIES AND METHODS OF THEIR USE
CA3010327A1 (en) Aryl substituted pyrimidines for use in influenza virus infection
BR112018075597A2 (en) 2-amino-4- (substituted amino) fluorinated phenyl carbamate derivatives
MX2022011972A (en) COMPOSITIONS COMPRISING ANTIBODIES AGAINST IL6R FOR THE TREATMENT OF UVEITIS AND MACULAR EDEMA, AND METHODS OF USE THEREOF.
MX2021015156A (en) Anti-pcrv antibodies that bind pcrv, compositions comprising anti-pcrv antibodies, and methods of use thereof.